The science of slowed gastrointestinal motility GLP-1 receptor agonists act on the gutbrain axis and are known to slow gastric emptying and overall gastrointestinal transit , contributing to early satiety and appetite suppression. As intestinal transit slows, the colon has more time to absorb water from stool , leading to hard, dry stools that are difficult to pass . Constipation is a common, dose-related adverse effect listed in FDA prescribing information for both Wegovy (semaglutide) and Zepbound (tirzepatide) and is most frequently reported during dose escalation , with improvement over time., Step-by-Step MD Protocol for Relief 1
Pripravite se, da boste videti tako dobro, kot se poutite, s popolnoma naravnim pristopom
[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Anoushiravani, M., Falsafi, T
Functional and biological insights of rCollinein-1, a recombinant serine protease from Crotalus durissus collilineatus